ID   HMCS2_HUMAN             Reviewed;         508 AA.
AC   P54868; B7Z8R3; D3Y5K6; Q5SZU2; Q6IBF4;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   12-APR-2017, entry version 165.
DE   RecName: Full=Hydroxymethylglutaryl-CoA synthase, mitochondrial;
DE            Short=HMG-CoA synthase;
DE            EC=2.3.3.10;
DE   AltName: Full=3-hydroxy-3-methylglutaryl coenzyme A synthase;
DE   Flags: Precursor;
GN   Name=HMGCS2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=7893153; DOI=10.1006/abbi.1995.1178;
RA   Mascaro C., Buesa C., Ortiz J.A., Haro D., Hegardt F.G.;
RT   "Molecular cloning and tissue expression of human mitochondrial 3-
RT   hydroxy-3-methylglutaryl-CoA synthase.";
RL   Arch. Biochem. Biophys. 317:385-390(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Liver;
RX   PubMed=9305755; DOI=10.1016/S0378-1119(97)00067-X;
RA   Boukaftane Y., Mitchell G.A.;
RT   "Cloning and characterization of the human mitochondrial 3-hydroxy-3-
RT   methylglutaryl CoA synthase gene.";
RL   Gene 195:121-126(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Liver;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 36-508 (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=7851882; DOI=10.1006/geno.1994.1542;
RA   Boukaftane Y., Duncan A., Wang S., Labuda D., Robert M.-F.,
RA   Sarrazin J., Schappert K.T., Mitchell G.A.;
RT   "Human mitochondrial HMG CoA synthase: liver cDNA and partial genomic
RT   cloning, chromosome mapping to 1p12-p13, and possible role in
RT   vertebrate evolution.";
RL   Genomics 23:552-559(1994).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 91-316 (ISOFORM 3), ALTERNATIVE
RP   SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=21952825; DOI=10.1007/s11033-011-1270-8;
RA   Puisac B., Ramos M., Arnedo M., Menao S., Gil-Rodriguez M.C.,
RA   Teresa-Rodrigo M.E., Pie A., de Karam J.C., Wesselink J.J.,
RA   Gimenez I., Ramos F.J., Casals N., Gomez-Puertas P., Hegardt F.G.,
RA   Pie J.;
RT   "Characterization of splice variants of the genes encoding human
RT   mitochondrial HMG-CoA lyase and HMG-CoA synthase, the main enzymes of
RT   the ketogenesis pathway.";
RL   Mol. Biol. Rep. 39:4777-4785(2012).
RN   [10]
RP   TISSUE SPECIFICITY.
RX   PubMed=16940161; DOI=10.1158/1541-7786.MCR-05-0267;
RA   Camarero N., Mascaro C., Mayordomo C., Vilardell F., Haro D.,
RA   Marrero P.F.;
RT   "Ketogenic HMGCS2 Is a c-Myc target gene expressed in differentiated
RT   cells of human colonic epithelium and down-regulated in colon
RT   cancer.";
RL   Mol. Cancer Res. 4:645-653(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-433 AND SER-440, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 51-508, SUBUNIT, ACTIVE SITE,
RP   AND SUBSTRATE-BINDING SITES.
RX   PubMed=20346956; DOI=10.1016/j.jmb.2010.03.034;
RA   Shafqat N., Turnbull A., Zschocke J., Oppermann U., Yue W.W.;
RT   "Crystal structures of human HMG-CoA synthase isoforms provide
RT   insights into inherited ketogenesis disorders and inhibitor design.";
RL   J. Mol. Biol. 398:497-506(2010).
RN   [13]
RP   VARIANTS HMGCS2D ARG-212 AND HIS-500.
RX   PubMed=11479731; DOI=10.1007/s004390100554;
RA   Aledo R., Zschocke J., Pie J., Mir C., Fiesel S., Mayatepek E.,
RA   Hoffmann G.F., Casals N., Hegardt F.G.;
RT   "Genetic basis of mitochondrial HMG-CoA synthase deficiency.";
RL   Hum. Genet. 109:19-23(2001).
RN   [14]
RP   VARIANT HMGCS2D LEU-174, AND CHARACTERIZATION OF VARIANT HMGCS2D
RP   LEU-174.
RX   PubMed=11228257; DOI=10.1203/00006450-200103000-00005;
RA   Bouchard L., Robert M.-F., Vinarov D., Stanley C.A., Thompson G.N.,
RA   Morris A., Leonard J.V., Quant P., Hsu B.Y.L., Boneh A.,
RA   Boukaftane Y., Ashmarina L., Wang S., Miziorko H., Mitchell G.A.;
RT   "Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency:
RT   clinical course and description of causal mutations in two patients.";
RL   Pediatr. Res. 49:326-331(2001).
RN   [15]
RP   VARIANTS HMGCS2D MET-54 AND CYS-167.
RX   PubMed=12647205; DOI=10.1007/s00431-002-1110-x;
RA   Wolf N.I., Rahman S., Clayton P.T., Zschocke J.;
RT   "Mitochondrial HMG-CoA synthase deficiency: identification of two
RT   further patients carrying two novel mutations.";
RL   Eur. J. Pediatr. 162:279-280(2003).
CC   -!- FUNCTION: This enzyme condenses acetyl-CoA with acetoacetyl-CoA to
CC       form HMG-CoA, which is the substrate for HMG-CoA reductase.
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + H(2)O + acetoacetyl-CoA = (S)-3-
CC       hydroxy-3-methylglutaryl-CoA + CoA. {ECO:0000255|PROSITE-
CC       ProRule:PRU10116}.
CC   -!- PATHWAY: Metabolic intermediate biosynthesis; (R)-mevalonate
CC       biosynthesis; (R)-mevalonate from acetyl-CoA: step 2/3.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:20346956}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P54868-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P54868-2; Sequence=VSP_042892;
CC         Note=No experimental confirmation available.;
CC       Name=3; Synonyms=HMGCS2delta4;
CC         IsoId=P54868-3; Sequence=VSP_047445;
CC   -!- TISSUE SPECIFICITY: Expression in liver is 200-fold higher than in
CC       any other tissue. Low expression in colon, kidney, testis, and
CC       pancreas. Very low expression in heart and skeletal muscle. Not
CC       detected in brain. The relative expression of isoform 3 (at mRNA
CC       level) is highest in heart (70%) and skeletal muscle (60%).
CC       {ECO:0000269|PubMed:16940161, ECO:0000269|PubMed:21952825,
CC       ECO:0000269|PubMed:7893153}.
CC   -!- PTM: Succinylated. Desuccinylated by SIRT5. Succinylation, at
CC       least at Lys-83 and Lys-310, inhibits the enzymatic activity.
CC       {ECO:0000250|UniProtKB:P54869}.
CC   -!- DISEASE: 3-hydroxy-3-methylglutaryl-CoA synthase-2 deficiency
CC       (HMGCS2D) [MIM:605911]: A metabolic disorder characterized by
CC       severe hypoketotic hypoglycemia, encephalopathy, and hepatomegaly.
CC       {ECO:0000269|PubMed:11228257, ECO:0000269|PubMed:11479731,
CC       ECO:0000269|PubMed:12647205}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the HMG-CoA synthase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X83618; CAA58593.1; -; mRNA.
DR   EMBL; U81859; AAB72036.1; -; Genomic_DNA.
DR   EMBL; U81851; AAB72036.1; JOINED; Genomic_DNA.
DR   EMBL; U81852; AAB72036.1; JOINED; Genomic_DNA.
DR   EMBL; U81853; AAB72036.1; JOINED; Genomic_DNA.
DR   EMBL; U81854; AAB72036.1; JOINED; Genomic_DNA.
DR   EMBL; U81855; AAB72036.1; JOINED; Genomic_DNA.
DR   EMBL; U81856; AAB72036.1; JOINED; Genomic_DNA.
DR   EMBL; U81857; AAB72036.1; JOINED; Genomic_DNA.
DR   EMBL; U81858; AAB72036.1; JOINED; Genomic_DNA.
DR   EMBL; CR456850; CAG33131.1; -; mRNA.
DR   EMBL; AK303777; BAH14049.1; -; mRNA.
DR   EMBL; AL589734; CAI22408.1; -; Genomic_DNA.
DR   EMBL; CH471122; EAW56709.1; -; Genomic_DNA.
DR   EMBL; BC044217; AAH44217.1; -; mRNA.
DR   EMBL; U12788; AAA92673.1; -; mRNA.
DR   EMBL; U12789; AAA92674.1; -; mRNA.
DR   EMBL; GU433940; ADD21696.1; -; mRNA.
DR   CCDS; CCDS53353.1; -. [P54868-2]
DR   CCDS; CCDS905.1; -. [P54868-1]
DR   PIR; S71623; S71623.
DR   RefSeq; NP_001159579.1; NM_001166107.1. [P54868-2]
DR   RefSeq; NP_005509.1; NM_005518.3. [P54868-1]
DR   RefSeq; XP_011539615.1; XM_011541313.1. [P54868-3]
DR   UniGene; Hs.59889; -.
DR   PDB; 2WYA; X-ray; 1.70 A; A/B/C/D=51-508.
DR   PDBsum; 2WYA; -.
DR   ProteinModelPortal; P54868; -.
DR   SMR; P54868; -.
DR   BioGrid; 109401; 5.
DR   IntAct; P54868; 1.
DR   STRING; 9606.ENSP00000358414; -.
DR   SwissLipids; SLP:000001249; -. [P54868-1]
DR   iPTMnet; P54868; -.
DR   PhosphoSitePlus; P54868; -.
DR   SwissPalm; P54868; -.
DR   BioMuta; HMGCS2; -.
DR   DMDM; 1708234; -.
DR   REPRODUCTION-2DPAGE; IPI00008934; -.
DR   MaxQB; P54868; -.
DR   PaxDb; P54868; -.
DR   PeptideAtlas; P54868; -.
DR   PRIDE; P54868; -.
DR   Ensembl; ENST00000369406; ENSP00000358414; ENSG00000134240. [P54868-1]
DR   Ensembl; ENST00000544913; ENSP00000439495; ENSG00000134240. [P54868-2]
DR   GeneID; 3158; -.
DR   KEGG; hsa:3158; -.
DR   UCSC; uc001eid.4; human. [P54868-1]
DR   CTD; 3158; -.
DR   DisGeNET; 3158; -.
DR   GeneCards; HMGCS2; -.
DR   H-InvDB; HIX0160007; -.
DR   HGNC; HGNC:5008; HMGCS2.
DR   HPA; CAB032906; -.
DR   HPA; HPA027423; -.
DR   HPA; HPA027442; -.
DR   MalaCards; HMGCS2; -.
DR   MIM; 600234; gene.
DR   MIM; 605911; phenotype.
DR   neXtProt; NX_P54868; -.
DR   OpenTargets; ENSG00000134240; -.
DR   Orphanet; 35701; 3-hydroxy-3-methylglutaryl-CoA synthase deficiency.
DR   PharmGKB; PA29338; -.
DR   eggNOG; KOG1393; Eukaryota.
DR   eggNOG; COG3425; LUCA.
DR   GeneTree; ENSGT00390000006096; -.
DR   HOGENOM; HOG000012351; -.
DR   HOVERGEN; HBG051912; -.
DR   InParanoid; P54868; -.
DR   KO; K01641; -.
DR   OMA; QWKQAGS; -.
DR   OrthoDB; EOG091G0791; -.
DR   PhylomeDB; P54868; -.
DR   TreeFam; TF105361; -.
DR   BioCyc; MetaCyc:HS05836-MONOMER; -.
DR   BRENDA; 2.3.3.10; 2681.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-77111; Synthesis of Ketone Bodies.
DR   UniPathway; UPA00058; UER00102.
DR   EvolutionaryTrace; P54868; -.
DR   GenomeRNAi; 3158; -.
DR   PRO; PR:P54868; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000134240; -.
DR   CleanEx; HS_HMGCS2; -.
DR   ExpressionAtlas; P54868; baseline and differential.
DR   Genevisible; P54868; HS.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:Ensembl.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0004421; F:hydroxymethylglutaryl-CoA synthase activity; ISS:UniProtKB.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0008299; P:isoprenoid biosynthetic process; IEA:InterPro.
DR   GO; GO:0046951; P:ketone body biosynthetic process; TAS:Reactome.
DR   Gene3D; 3.40.47.10; -; 2.
DR   InterPro; IPR000590; HMG_CoA_synt_AS.
DR   InterPro; IPR013746; HMG_CoA_synt_C_dom.
DR   InterPro; IPR013528; HMG_CoA_synth_N.
DR   InterPro; IPR010122; HMG_CoA_synthase_euk.
DR   InterPro; IPR016039; Thiolase-like.
DR   Pfam; PF08540; HMG_CoA_synt_C; 1.
DR   Pfam; PF01154; HMG_CoA_synt_N; 1.
DR   SUPFAM; SSF53901; SSF53901; 3.
DR   TIGRFAMs; TIGR01833; HMG-CoA-S_euk; 1.
DR   PROSITE; PS01226; HMG_COA_SYNTHASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing;
KW   Cholesterol biosynthesis; Cholesterol metabolism; Complete proteome;
KW   Disease mutation; Lipid biosynthesis; Lipid metabolism; Mitochondrion;
KW   Phosphoprotein; Reference proteome; Steroid biosynthesis;
KW   Steroid metabolism; Sterol biosynthesis; Sterol metabolism;
KW   Transferase; Transit peptide.
FT   TRANSIT       1     37       Mitochondrion. {ECO:0000305}.
FT   CHAIN        38    508       Hydroxymethylglutaryl-CoA synthase,
FT                                mitochondrial.
FT                                /FTId=PRO_0000013483.
FT   ACT_SITE    132    132       Proton donor/acceptor.
FT                                {ECO:0000305|PubMed:20346956}.
FT   ACT_SITE    166    166       Acyl-thioester intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10116,
FT                                ECO:0000269|PubMed:20346956}.
FT   ACT_SITE    301    301       Proton donor/acceptor.
FT                                {ECO:0000305|PubMed:20346956}.
FT   BINDING      80     80       Substrate.
FT   BINDING     204    204       Substrate.
FT   BINDING     258    258       Substrate.
FT   BINDING     380    380       Substrate.
FT   MOD_RES      52     52       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P54869}.
FT   MOD_RES      83     83       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P54869}.
FT   MOD_RES      83     83       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P54869}.
FT   MOD_RES     221    221       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P54869}.
FT   MOD_RES     243    243       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P54869}.
FT   MOD_RES     256    256       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P54869}.
FT   MOD_RES     256    256       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P54869}.
FT   MOD_RES     306    306       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P54869}.
FT   MOD_RES     310    310       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P54869}.
FT   MOD_RES     310    310       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q2KIE6}.
FT   MOD_RES     333    333       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P54869}.
FT   MOD_RES     342    342       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P54869}.
FT   MOD_RES     342    342       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P54869}.
FT   MOD_RES     350    350       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P54869}.
FT   MOD_RES     350    350       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P54869}.
FT   MOD_RES     354    354       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P54869}.
FT   MOD_RES     354    354       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P54869}.
FT   MOD_RES     358    358       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P54869}.
FT   MOD_RES     358    358       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P54869}.
FT   MOD_RES     433    433       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     437    437       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P54869}.
FT   MOD_RES     440    440       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     447    447       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P54869}.
FT   MOD_RES     447    447       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P54869}.
FT   MOD_RES     456    456       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P54869}.
FT   MOD_RES     473    473       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P54869}.
FT   MOD_RES     473    473       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P54869}.
FT   MOD_RES     477    477       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P22791}.
FT   VAR_SEQ     187    228       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042892.
FT   VAR_SEQ     229    283       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:21952825}.
FT                                /FTId=VSP_047445.
FT   VARIANT      54     54       V -> M (in HMGCS2D; dbSNP:rs28937320).
FT                                {ECO:0000269|PubMed:12647205}.
FT                                /FTId=VAR_032757.
FT   VARIANT     167    167       Y -> C (in HMGCS2D; dbSNP:rs137852640).
FT                                {ECO:0000269|PubMed:12647205}.
FT                                /FTId=VAR_032758.
FT   VARIANT     174    174       F -> L (in HMGCS2D; reduced peptide
FT                                level; no enzymatic activity;
FT                                dbSNP:rs137852636).
FT                                {ECO:0000269|PubMed:11228257}.
FT                                /FTId=VAR_032711.
FT   VARIANT     212    212       G -> R (in HMGCS2D; dbSNP:rs137852638).
FT                                {ECO:0000269|PubMed:11479731}.
FT                                /FTId=VAR_032759.
FT   VARIANT     500    500       R -> H (in HMGCS2D; dbSNP:rs137852639).
FT                                {ECO:0000269|PubMed:11479731}.
FT                                /FTId=VAR_032760.
FT   CONFLICT    234    234       H -> Y (in Ref. 3; CAG33131).
FT                                {ECO:0000305}.
FT   CONFLICT    385    385       S -> T (in Ref. 3; CAG33131).
FT                                {ECO:0000305}.
FT   STRAND       55     62       {ECO:0000244|PDB:2WYA}.
FT   STRAND       65     69       {ECO:0000244|PDB:2WYA}.
FT   HELIX        70     76       {ECO:0000244|PDB:2WYA}.
FT   HELIX        83     88       {ECO:0000244|PDB:2WYA}.
FT   STRAND       92     94       {ECO:0000244|PDB:2WYA}.
FT   HELIX       102    117       {ECO:0000244|PDB:2WYA}.
FT   HELIX       121    123       {ECO:0000244|PDB:2WYA}.
FT   STRAND      124    130       {ECO:0000244|PDB:2WYA}.
FT   STRAND      137    139       {ECO:0000244|PDB:2WYA}.
FT   HELIX       141    145       {ECO:0000244|PDB:2WYA}.
FT   HELIX       146    148       {ECO:0000244|PDB:2WYA}.
FT   HELIX       150    152       {ECO:0000244|PDB:2WYA}.
FT   STRAND      161    164       {ECO:0000244|PDB:2WYA}.
FT   HELIX       165    167       {ECO:0000244|PDB:2WYA}.
FT   HELIX       168    180       {ECO:0000244|PDB:2WYA}.
FT   STRAND      189    198       {ECO:0000244|PDB:2WYA}.
FT   HELIX       206    208       {ECO:0000244|PDB:2WYA}.
FT   STRAND      210    221       {ECO:0000244|PDB:2WYA}.
FT   STRAND      223    226       {ECO:0000244|PDB:2WYA}.
FT   STRAND      232    235       {ECO:0000244|PDB:2WYA}.
FT   STRAND      240    242       {ECO:0000244|PDB:2WYA}.
FT   HELIX       255    283       {ECO:0000244|PDB:2WYA}.
FT   HELIX       292    294       {ECO:0000244|PDB:2WYA}.
FT   STRAND      296    300       {ECO:0000244|PDB:2WYA}.
FT   HELIX       305    322       {ECO:0000244|PDB:2WYA}.
FT   HELIX       325    331       {ECO:0000244|PDB:2WYA}.
FT   HELIX       333    338       {ECO:0000244|PDB:2WYA}.
FT   HELIX       343    347       {ECO:0000244|PDB:2WYA}.
FT   HELIX       350    367       {ECO:0000244|PDB:2WYA}.
FT   HELIX       369    372       {ECO:0000244|PDB:2WYA}.
FT   HELIX       373    378       {ECO:0000244|PDB:2WYA}.
FT   HELIX       382    384       {ECO:0000244|PDB:2WYA}.
FT   HELIX       385    396       {ECO:0000244|PDB:2WYA}.
FT   HELIX       399    402       {ECO:0000244|PDB:2WYA}.
FT   STRAND      406    413       {ECO:0000244|PDB:2WYA}.
FT   TURN        414    416       {ECO:0000244|PDB:2WYA}.
FT   STRAND      417    425       {ECO:0000244|PDB:2WYA}.
FT   HELIX       434    440       {ECO:0000244|PDB:2WYA}.
FT   TURN        441    444       {ECO:0000244|PDB:2WYA}.
FT   HELIX       445    450       {ECO:0000244|PDB:2WYA}.
FT   STRAND      452    455       {ECO:0000244|PDB:2WYA}.
FT   HELIX       457    470       {ECO:0000244|PDB:2WYA}.
FT   HELIX       482    484       {ECO:0000244|PDB:2WYA}.
FT   STRAND      490    495       {ECO:0000244|PDB:2WYA}.
FT   STRAND      501    505       {ECO:0000244|PDB:2WYA}.
SQ   SEQUENCE   508 AA;  56635 MW;  BD362D631F7C3C80 CRC64;
     MQRLLTPVKR ILQLTRAVQE TSLTPARLLP VAHQRFSTAS AVPLAKTDTW PKDVGILALE
     VYFPAQYVDQ TDLEKYNNVE AGKYTVGLGQ TRMGFCSVQE DINSLCLTVV QRLMERIQLP
     WDSVGRLEVG TETIIDKSKA VKTVLMELFQ DSGNTDIEGI DTTNACYGGT ASLFNAANWM
     ESSSWDGRYA MVVCGDIAVY PSGNARPTGG AGAVAMLIGP KAPLALERGL RGTHMENVYD
     FYKPNLASEY PIVDGKLSIQ CYLRALDRCY TSYRKKIQNQ WKQAGSDRPF TLDDLQYMIF
     HTPFCKMVQK SLARLMFNDF LSASSDTQTS LYKGLEAFGG LKLEDTYTNK DLDKALLKAS
     QDMFDKKTKA SLYLSTHNGN MYTSSLYGCL ASLLSHHSAQ ELAGSRIGAF SYGSGLAASF
     FSFRVSQDAA PGSPLDKLVS STSDLPKRLA SRKCVSPEEF TEIMNQREQF YHKVNFSPPG
     DTNSLFPGTW YLERVDEQHR RKYARRPV
//
